Abstract
Measurement of viral nucleic acid in serum is often a valuable adjunct to the management of viral infections (1). In hepatitis B, tests for hepatitis B virus (HBV) DNA have been used widely (Table 1), but their interpretation and significance have yet to be defined. HBV DNA assays are limited by lack of standardization and variable sensitivity. Because HBV may circulate in serum at high levels (as high as 1010 virions/mL), direct molecular hybridization assays are capable of detecting HBV DNA in a high proportion of patients, particularly those with active disease and both HBsAg (hepatitis B surface antigen) and HBeAg (hepatitis B e antigen) in serum. Commercial assays comprise the liquid hybridization assay (Genostics™, Abbott Laboratories, Chicago, IL), the hybridization capture assay (Digene, HC II), and branched DNA (bDNA) signal amplification assay (Versant, Bayer Diagnostics). Furthermore, a quantitative polymerase chain reaction (PCR) assay for HBV DNA has been developed (Amplicor Monitor HBV, Roche Diagnostics); it detects HBV DNA in a higher proportion of patients with chronic hepatitis B and often yields positive results, even in HBsAg carriers without apparent disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Lok, A.S., Heathcote, E.J., Hoofnagle, J.H. (2001) Management of hepatitis B: 2000—summary of a workshop. Gastroenterology 120, 1828–1853.
Kuhns, M.C., McNamara, A.L., Cabal, C.M., et al. (1988) A new assay for the quantitative detection of hepatitis B viral DNA in human serum. In: Zuckerman, A.J. (ed.) Viral Hepatitis and Liver Disease, Alan Liss, New York, 258–262.
Kuhns, M.C., McNamara, A.L., Perrillo, R.P., Cabal, C.M., and Campbel, C.R. (1989) Quantitation of hepatitis B viral DNA by solution hybridization: comparison with DNA polymerase and hepatitis B e antigen during antiviral therapy. J. Med. Virol. 27, 274–281.
Kuhns, M., Thiers, V., Courouce, A., Scotto, J., Tiollais, P., and Bréchot, C. (1984) Quantitative detection of HBV DNA in human serum. In: Vyas, G., Dienstag, J., Hoofnagle, J. (eds.) Viral Hepatitis and Liver Disease, Grune and Stratton, Orlando, FL, 665–670.
Hendricks, D.A., Stowe, B.J., Hoo, B.S., et al. (1995) Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Am. J. Clin. Pathol. 104, 537–546.
Chen, C.H., Wang, J.T., Lee, C.Z., Sheu, J.C., Wang, T.H., and Chen, D.S. (1995) Quantitative detection of hepatitis B virus DNA in human sera by branched-DNA signal amplification. J. Virol. Methods 53, 131–137.
Urdea, M.S. (1992) Theoretical aspects of nucleic acid standardization for HBV DNA detection. Report on the Sixth Eurohep Workshop, 3.1.2c.
Butterworth, L.-A., Prior, S.L., Buda, P.J., Faoagali, J.L., and Cooksley, G.E. (1996) Comparison of four methods for quantitative measurement of hepatitis B viral DNA. J. Hepatol. 24, 686–691.
Pawlotsky, J.M., Bastie, A., Lonjon, I., et al. (1997) What technique should be used for routine detection and quantification of HBV DNA in clinical samples? J. Virol. Methods 65, 245–253.
Niesters, H.G., Krajden, M., Cork, L., et al. (2000) A multicenter study evaluation of the digene hybrid capture II signal amplification technique for detection of hepatitis B virus DNA in serum samples and testing of EUROHEP standards. J. Clin. Microbiol. 38, 2150–2155.
Kessler, H.H., Pierer, K., Dragon, E., et al. (1998) Evaluation of a new assay for HBV DNA quantitation in patients with chronic hepatitis B. Clin. Diagn. Virol. 9, 37–43.
Gerken, G., Gomes, J., Lampertico, P., et al. (1998) Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay. J. Virol. Methods 74, 155–165.
Noborg, U., Gusdal, A., Pisa, E.K., Hedrum, A., and Lindh, M. (1999) Automated quantitative analysis of hepatitis B virus DNA by using the Cobas Amplicor HBV Monitor test. J. Clin. Microbiol. 37, 2793–2797.
Ide, T., Kumashiro, R., Hino, T., et al. (2001) Transcription-mediated amplification is more useful in the follow-up of patients with chronic hepatitis B treated with lamivudine. Hepatol. Res. 21, 76–84.
Trippler, M., Hampl, H., Goergen, B., et al. (1996) Ligase chain reaction (LCR) assay for semi-quantitative detection of HBV DNA in mononuclear leukocytes if patients with chronic hepatitis B. J. Viral Hepatitis 3, 267–272.
Yates, S., Penning, M., Goudsmit, J., et al. (2001) Quantitative detection of hepatitis B virus DNA by real-time nucleic acid sequence-based amplification with molecular beacon detection. J. Clin. Microbiol. 39, 3656–3665.
Erhardt, A., Schaefer, S., Athanassiou, N., Kann, M., and Gerlich, W.H. (1996) Quantitative assay of PCR-amplified hepatitis B virus DNA using a peroxidase-labelled DNA probe and enhanced chemiluminescence. J. Clin. Microbiol. 34, 1885–1891.
Lai, V.C., Guan, R., Wood, M.L., Lo, S.K., Yuen, M.F., and Lai, C.L. (1999) Nucleic acid-based cross-linking assay for detection and quantification of hepatitis B virus DNA. J.Clin. Microbiol. 37, 161–164.
Cane, P.A., Cook, P., Ratcliffe, D., Mutimer, D., and Pillay, D. (1999) Use of real-time PCR and fluorimetry to detect lamivudine resistance-associated mutations in hepatitis B virus. Antimicrob. Agents Chemother. 43, 1600–1608.
Defoort, J.P., Martin, M., Casano, B., Prato, S., Camilla, C., and Fert, V. (2000) Simultaneous detection of multiplex-amplified human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA using a flow cytometer microsphere-based hybridization assay. J. Clin. Microbiol. 38, 1066–1071.
Loeb, K.R., Jerome, K.R., Goddard, J., Huang, M., Cent, A., and Corey, L. (2000) High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system. Hepatology 32, 626–629.
Chen, R.W., Piiparinen, H., Seppanen, M., Koskela, P., Sarna, S., and Lappalainen, M. (2001) Real-time PCR for detection and quantitation of hepatitis B virus DNA. J. Med. Virol. 65, 250–256.
Pas, S.D., Fries, E., de Man, R.A., Osterhaus, A.D.M.E., and Niesters, H.G.M. (2000) Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays. J. Clin. Microbiol. 38, 2897–2901.
Kapke, G.E., Watson, G., Sheffler, S., Hunt, D., and Frederick, C. (1997) Comparison of the Chiron Quantiplex branched DNA (bDNA) assay and the Abbott Genostics solution hybridization assay for quantification of hepatitis B viral DNA. J. Viral Hepat. 4, 67–75.
Zaaijer, H.L., ter Borg, F., Cuypers, H.T., Hermus, M.C., and Lelie, P.N. (1994) Comparison of methods for detection of hepatitis B virus DNA. J. Clin. Microbiol. 32, 2088–2091.
Khakoo, S.I., Soni, P.N., and Dusheiko, G.M. (1996) A clinical evaluation of a new method for HBV DNA quantitation in patients with chronic hepatitis B. J. Med. Virol. 50, 112–116.
Hwang, S.J., Lee, S.D., Lu, R.H., et al. (1996) Comparison of three different hybridization assays in the quantitative measurement of serum hepatitis B virus DNA. J. Virol. Methods 62, 123–129.
Krajden, M., Minor, J., Cork, L., and Comanor, L. (1998) Multi-measurement method comparison of three commercial hepatitis B virus DNA quantification assays. J. Viral Hepat. 5, 415–422.
Ho, S.K.N., Chan, T.M., Cheng, I.K.P., and Lai, K.N. (1999) Comparison of the second-generation Digene hybrid capture assay with the branched DNA assay for measurement of hepatitis B virus DNA in serum. J. Clin. Microbiol. 37, 2461–2465.
Pawlotsky, J.M., Bastie, A., Hezode, C., et al. (2000) Routine detection and quantification of hepatitis B virus DNA in clinical laboratories: performance of three commercial assays. J. Virol. Methods 85, 11–21.
Chan, H.L., Leung, N.W., Lau, T.C., Wong, M.L., and Sung, J.J. (2000) Comparison of three different sensitive assays for hepatitis B virus DNA in monitoring of responses to antiviral therapy. J. Clin. Microbiol. 38, 3205–3208.
Gerlich, W.H., Heermann, K.-H., Thomssen, R., and the Eurohep Group (1995) Quantitative assays for hepatitis B virus DNA: standardization and quality control. Viral Hep. Rev. 1, 53–57.
Heermann, K.-H., Gerlich, W.H., Chudy, M., Schaefer, S., Thomssen, R., and the Eurohep Pathobiology Group (1999) Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. J. Clin. Microbiol. 37, 68–73.
Quint, W.G., Heijtink, R.A., Schirm, J., Gerlich, W.H., and Niesters, H.G. (1995) Reliability of methods for hepatitis B virus DNA detection. J. Clin. Microbiol. 33, 225–228.
Lindh, M., Horal, P., Dhillon, A.P., and Norkrans, G. (2000) Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J. Viral Hepat. 7, 258–267.
Cacciola, I., Pollicino, T., Squadrito, G., et al. (2000) Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. Hepatology 31, 507–512.
Otake, K., and Nishioka, K. (2000) Nucleic acid amplification testing of hepatitis B virus. Lancet 355, 1460.
Hunt, C.M., McGill, J.M., Allen, M.I., and Condreay, L.D. (2000) Clinical relevance of hepatitis B viral mutations. Hepatology 31, 1037–1044.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc.
About this protocol
Cite this protocol
Zeuzemro, S. (2004). Overview of Commercial HBV Assay Systems. In: Hamatake, R.K., Lau, J.Y.N. (eds) Hepatitis B and D Protocols. Methods in Molecular Medicine, vol 95. Humana Press. https://doi.org/10.1385/1-59259-669-X:3
Download citation
DOI: https://doi.org/10.1385/1-59259-669-X:3
Publisher Name: Humana Press
Print ISBN: 978-1-58829-105-9
Online ISBN: 978-1-59259-669-0
eBook Packages: Springer Protocols